Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

VLTO vs DHR vs WAT vs TMO vs A

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
VLTO
Veralto Corporation

Industrial - Pollution & Treatment Controls

IndustrialsNYSE • US
Market Cap$22.11B
5Y Perf.+4.9%
DHR
Danaher Corporation

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$124.33B
5Y Perf.-20.1%
WAT
Waters Corporation

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$22.83B
5Y Perf.+27.7%
TMO
Thermo Fisher Scientific Inc.

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$176.36B
5Y Perf.-6.2%
A
Agilent Technologies, Inc.

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$33.58B
5Y Perf.+6.1%

VLTO vs DHR vs WAT vs TMO vs A — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
VLTO logoVLTO
DHR logoDHR
WAT logoWAT
TMO logoTMO
A logoA
IndustryIndustrial - Pollution & Treatment ControlsMedical - Diagnostics & ResearchMedical - Diagnostics & ResearchMedical - Diagnostics & ResearchMedical - Diagnostics & Research
Market Cap$22.11B$124.33B$22.83B$176.36B$33.58B
Revenue (TTM)$5.59B$24.78B$3.77B$45.20B$7.07B
Net Income (TTM)$969M$3.69B$449M$6.86B$1.29B
Gross Margin59.9%60.7%55.0%39.4%38.8%
Operating Margin23.1%21.0%17.1%17.8%20.6%
Forward P/E20.9x20.8x24.4x19.1x19.9x
Total Debt$2.67B$18.42B$1.41B$40.85B$3.35B
Cash & Equiv.$2.03B$4.62B$588M$9.86B$1.79B

VLTO vs DHR vs WAT vs TMO vs ALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

VLTO
DHR
WAT
TMO
A
StockSep 23May 26Return
Veralto Corporation (VLTO)100104.9+4.9%
Danaher Corporation (DHR)10079.9-20.1%
Waters Corporation (WAT)100127.7+27.7%
Thermo Fisher Scien… (TMO)10093.8-6.2%
Agilent Technologie… (A)100106.1+6.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: VLTO vs DHR vs WAT vs TMO vs A

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: VLTO and TMO are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. Thermo Fisher Scientific Inc. is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. A and WAT also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
VLTO
Veralto Corporation
The Growth Play

VLTO has the current edge in this matchup, primarily because of its strength in growth exposure.

  • Rev growth 6.0%, EPS growth 12.6%, 3Y rev CAGR 4.2%
  • Beta 0.66 vs A's 1.23
  • 12.9% ROA vs DHR's 4.5%, ROIC 25.7% vs 5.9%
Best for: growth exposure
DHR
Danaher Corporation
The Defensive Pick

DHR is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 0.94, Low D/E 35.1%, current ratio 1.87x
Best for: sleep-well-at-night
WAT
Waters Corporation
The Growth Leader

WAT is the clearest fit if your priority is growth.

  • 7.0% revenue growth vs DHR's 2.9%
Best for: growth
TMO
Thermo Fisher Scientific Inc.
The Long-Run Compounder

TMO is the #2 pick in this set and the best alternative if long-term compounding is your priority.

  • 229.1% 10Y total return vs DHR's 219.3%
  • Lower P/E (19.1x vs 24.4x)
  • +16.8% vs DHR's -8.3%
Best for: long-term compounding
A
Agilent Technologies, Inc.
The Income Pick

A ranks third and is worth considering specifically for income & stability and valuation efficiency.

  • Dividend streak 10 yrs, beta 1.23, yield 0.8%
  • PEG 1.35 vs DHR's 34.35
  • Beta 1.23, yield 0.8%, current ratio 1.96x
  • 18.3% margin vs WAT's 11.9%
Best for: income & stability and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthWAT logoWAT7.0% revenue growth vs DHR's 2.9%
ValueTMO logoTMOLower P/E (19.1x vs 24.4x)
Quality / MarginsA logoA18.3% margin vs WAT's 11.9%
Stability / SafetyVLTO logoVLTOBeta 0.66 vs A's 1.23
DividendsA logoA0.8% yield, 10-year raise streak, vs TMO's 0.4%, (1 stock pays no dividend)
Momentum (1Y)TMO logoTMO+16.8% vs DHR's -8.3%
Efficiency (ROA)VLTO logoVLTO12.9% ROA vs DHR's 4.5%, ROIC 25.7% vs 5.9%

VLTO vs DHR vs WAT vs TMO vs A — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

VLTOVeralto Corporation
FY 2025
Revenue from Contract with Customer, Measurement, Recurring
61.0%$3.4B
Revenue from Contract with Customer, Measurement, Nonrecurring
39.0%$2.1B
DHRDanaher Corporation
FY 2025
Revenue from Contract with Customer, Measurement, Recurring
81.9%$20.1B
Revenue from Contract with Customer, Measurement, Nonrecurring
18.1%$4.4B
WATWaters Corporation
FY 2025
Waters Instrument Systems
34.8%$1.1B
Waters Service
34.1%$1.1B
Chemistry Consumables
19.9%$631M
Ta Instrument Systems
7.7%$244M
Ta Service
3.4%$108M
TMOThermo Fisher Scientific Inc.
FY 2025
Consumables
41.9%$18.7B
Service
41.7%$18.6B
Instruments
16.4%$7.3B
AAgilent Technologies, Inc.
FY 2025
Agilent CrossLab
41.9%$2.9B
Life Sciences and Applied Markets
39.2%$2.7B
Applied Markets
18.9%$1.3B

VLTO vs DHR vs WAT vs TMO vs A — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLVLTOLAGGINGTMO

Income & Cash Flow (Last 12 Months)

Evenly matched — VLTO and DHR each lead in 2 of 6 comparable metrics.

TMO is the larger business by revenue, generating $45.2B annually — 12.0x WAT's $3.8B. A is the more profitable business, keeping 18.3% of every revenue dollar as net income compared to WAT's 11.9%. On growth, WAT holds the edge at +91.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricVLTO logoVLTOVeralto Corporati…DHR logoDHRDanaher Corporati…WAT logoWATWaters CorporationTMO logoTMOThermo Fisher Sci…A logoAAgilent Technolog…
RevenueTrailing 12 months$5.6B$24.8B$3.8B$45.2B$7.1B
EBITDAEarnings before interest/tax$1.4B$7.2B$953M$10.5B$1.7B
Net IncomeAfter-tax profit$969M$3.7B$449M$6.9B$1.3B
Free Cash FlowCash after capex$1.0B$5.3B$264M$6.7B$993M
Gross MarginGross profit ÷ Revenue+59.9%+60.7%+55.0%+39.4%+38.8%
Operating MarginEBIT ÷ Revenue+23.1%+21.0%+17.1%+17.8%+20.6%
Net MarginNet income ÷ Revenue+17.3%+14.9%+11.9%+15.2%+18.3%
FCF MarginFCF ÷ Revenue+18.6%+21.4%+7.0%+14.9%+14.1%
Rev. Growth (YoY)Latest quarter vs prior year+6.8%+3.7%+91.5%+6.2%+7.0%
EPS Growth (YoY)Latest quarter vs prior year+13.3%+9.8%-142.9%+11.3%-3.6%
Evenly matched — VLTO and DHR each lead in 2 of 6 comparable metrics.

Valuation Metrics

VLTO leads this category, winning 3 of 7 comparable metrics.

At 23.6x trailing earnings, VLTO trades at a 32% valuation discount to DHR's 34.9x P/E. Adjusting for growth (PEG ratio), A offers better value at 1.76x vs DHR's 34.35x — a lower PEG means you pay less per unit of expected earnings growth.

MetricVLTO logoVLTOVeralto Corporati…DHR logoDHRDanaher Corporati…WAT logoWATWaters CorporationTMO logoTMOThermo Fisher Sci…A logoAAgilent Technolog…
Market CapShares × price$22.1B$124.3B$22.8B$176.4B$33.6B
Enterprise ValueMkt cap + debt − cash$22.8B$138.1B$23.7B$207.4B$35.1B
Trailing P/EPrice ÷ TTM EPS23.60x34.85x32.55x26.75x25.96x
Forward P/EPrice ÷ next-FY EPS est.20.94x20.82x24.36x19.11x19.87x
PEG RatioP/E ÷ EPS growth rate34.35x6.29x12.67x1.76x
EV / EBITDAEnterprise value multiple16.79x18.21x21.51x19.04x19.89x
Price / SalesMarket cap ÷ Revenue4.02x5.06x7.21x3.96x4.83x
Price / BookPrice ÷ Book value/share7.15x2.38x8.17x3.34x5.00x
Price / FCFMarket cap ÷ FCF21.81x23.64x42.30x28.02x29.15x
VLTO leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

VLTO leads this category, winning 5 of 9 comparable metrics.

VLTO delivers a 33.4% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $7 for DHR. DHR carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to VLTO's 0.86x. On the Piotroski fundamental quality scale (0–9), DHR scores 7/9 vs WAT's 4/9, reflecting strong financial health.

MetricVLTO logoVLTOVeralto Corporati…DHR logoDHRDanaher Corporati…WAT logoWATWaters CorporationTMO logoTMOThermo Fisher Sci…A logoAAgilent Technolog…
ROE (TTM)Return on equity+33.4%+7.1%+8.0%+13.2%+18.7%
ROA (TTM)Return on assets+12.9%+4.5%+4.6%+6.4%+10.1%
ROICReturn on invested capital+25.7%+5.9%+20.3%+7.5%+13.5%
ROCEReturn on capital employed+23.7%+7.0%+18.5%+9.1%+14.5%
Piotroski ScoreFundamental quality 0–957465
Debt / EquityFinancial leverage0.86x0.35x0.55x0.76x0.50x
Net DebtTotal debt minus cash$642M$13.8B$820M$31.0B$1.6B
Cash & Equiv.Liquid assets$2.0B$4.6B$588M$9.9B$1.8B
Total DebtShort + long-term debt$2.7B$18.4B$1.4B$40.9B$3.4B
Interest CoverageEBIT ÷ Interest expense13.96x18.13x6.72x5.89x19.53x
VLTO leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

WAT leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in VLTO five years ago would be worth $11,141 today (with dividends reinvested), compared to $7,893 for DHR. Over the past 12 months, TMO leads with a +16.8% total return vs DHR's -8.3%. The 3-year compound annual growth rate (CAGR) favors WAT at 5.7% vs DHR's -5.5% — a key indicator of consistent wealth creation.

MetricVLTO logoVLTOVeralto Corporati…DHR logoDHRDanaher Corporati…WAT logoWATWaters CorporationTMO logoTMOThermo Fisher Sci…A logoAAgilent Technolog…
YTD ReturnYear-to-date-9.8%-23.6%-8.3%-19.8%-13.6%
1-Year ReturnPast 12 months-7.1%-8.3%+1.4%+16.8%+11.3%
3-Year ReturnCumulative with dividends+11.4%-15.5%+18.1%-11.7%-8.2%
5-Year ReturnCumulative with dividends+11.4%-21.1%+11.3%+2.8%-8.0%
10-Year ReturnCumulative with dividends+11.4%+219.3%+162.0%+229.1%+205.7%
CAGR (3Y)Annualised 3-year return+3.7%-5.5%+5.7%-4.0%-2.8%
WAT leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — VLTO and WAT each lead in 1 of 2 comparable metrics.

VLTO is the less volatile stock with a 0.66 beta — it tends to amplify market swings less than A's 1.23 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WAT currently trades 84.6% from its 52-week high vs DHR's 72.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricVLTO logoVLTOVeralto Corporati…DHR logoDHRDanaher Corporati…WAT logoWATWaters CorporationTMO logoTMOThermo Fisher Sci…A logoAAgilent Technolog…
Beta (5Y)Sensitivity to S&P 5000.66x0.94x1.07x1.10x1.23x
52-Week HighHighest price in past year$110.11$242.80$414.15$643.99$160.27
52-Week LowLowest price in past year$84.99$172.06$275.05$385.46$104.79
% of 52W HighCurrent price vs 52-week peak+80.6%+72.3%+84.6%+73.7%+74.0%
RSI (14)Momentum oscillator 0–10041.833.064.943.152.5
Avg Volume (50D)Average daily shares traded1.7M4.2M999K1.9M2.0M
Evenly matched — VLTO and WAT each lead in 1 of 2 comparable metrics.

Analyst Outlook

A leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: VLTO as "Hold", DHR as "Buy", WAT as "Hold", TMO as "Buy", A as "Buy". Consensus price targets imply 40.6% upside for DHR (target: $247) vs 14.9% for WAT (target: $403). For income investors, A offers the higher dividend yield at 0.84% vs TMO's 0.36%.

MetricVLTO logoVLTOVeralto Corporati…DHR logoDHRDanaher Corporati…WAT logoWATWaters CorporationTMO logoTMOThermo Fisher Sci…A logoAAgilent Technolog…
Analyst RatingConsensus buy/hold/sellHoldBuyHoldBuyBuy
Price TargetConsensus 12-month target$106.14$247.00$402.57$654.67$166.00
# AnalystsCovering analysts1242344238
Dividend YieldAnnual dividend ÷ price+0.5%+0.7%+0.4%+0.8%
Dividend StreakConsecutive years of raises211810
Dividend / ShareAnnual DPS$0.44$1.23$1.69$0.99
Buyback YieldShare repurchases ÷ mkt cap0.0%+2.5%+0.1%+1.7%+1.3%
A leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

VLTO leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). WAT leads in 1 (Total Returns). 2 tied.

Best OverallVeralto Corporation (VLTO)Leads 2 of 6 categories
Loading custom metrics...

VLTO vs DHR vs WAT vs TMO vs A: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is VLTO or DHR or WAT or TMO or A a better buy right now?

For growth investors, Waters Corporation (WAT) is the stronger pick with 7.

0% revenue growth year-over-year, versus 2. 9% for Danaher Corporation (DHR). Veralto Corporation (VLTO) offers the better valuation at 23. 6x trailing P/E (20. 9x forward), making it the more compelling value choice. Analysts rate Danaher Corporation (DHR) a "Buy" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — VLTO or DHR or WAT or TMO or A?

On trailing P/E, Veralto Corporation (VLTO) is the cheapest at 23.

6x versus Danaher Corporation at 34. 9x. On forward P/E, Thermo Fisher Scientific Inc. is actually cheaper at 19. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Agilent Technologies, Inc. wins at 1. 35x versus Danaher Corporation's 34. 35x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — VLTO or DHR or WAT or TMO or A?

Over the past 5 years, Veralto Corporation (VLTO) delivered a total return of +11.

4%, compared to -21. 1% for Danaher Corporation (DHR). Over 10 years, the gap is even starker: TMO returned +229. 1% versus VLTO's +11. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — VLTO or DHR or WAT or TMO or A?

By beta (market sensitivity over 5 years), Veralto Corporation (VLTO) is the lower-risk stock at 0.

66β versus Agilent Technologies, Inc. 's 1. 23β — meaning A is approximately 87% more volatile than VLTO relative to the S&P 500. On balance sheet safety, Danaher Corporation (DHR) carries a lower debt/equity ratio of 35% versus 86% for Veralto Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — VLTO or DHR or WAT or TMO or A?

By revenue growth (latest reported year), Waters Corporation (WAT) is pulling ahead at 7.

0% versus 2. 9% for Danaher Corporation (DHR). On earnings-per-share growth, the picture is similar: Veralto Corporation grew EPS 12. 6% year-over-year, compared to -4. 7% for Danaher Corporation. Over a 3-year CAGR, VLTO leads at 4. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — VLTO or DHR or WAT or TMO or A?

Waters Corporation (WAT) is the more profitable company, earning 20.

3% net margin versus 14. 7% for Danaher Corporation — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WAT leads at 28. 2% versus 18. 2% for TMO. At the gross margin level — before operating expenses — DHR leads at 60. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is VLTO or DHR or WAT or TMO or A more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Agilent Technologies, Inc. (A) is the more undervalued stock at a PEG of 1. 35x versus Danaher Corporation's 34. 35x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Thermo Fisher Scientific Inc. (TMO) trades at 19. 1x forward P/E versus 24. 4x for Waters Corporation — 5. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DHR: 40. 6% to $247. 00.

08

Which pays a better dividend — VLTO or DHR or WAT or TMO or A?

In this comparison, A (0.

8% yield), DHR (0. 7% yield), VLTO (0. 5% yield), TMO (0. 4% yield) pay a dividend. WAT does not pay a meaningful dividend and should not be held primarily for income.

09

Is VLTO or DHR or WAT or TMO or A better for a retirement portfolio?

For long-horizon retirement investors, Danaher Corporation (DHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

94), 0. 7% yield, +219. 3% 10Y return). Both have compounded well over 10 years (DHR: +219. 3%, WAT: +162. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between VLTO and DHR and WAT and TMO and A?

These companies operate in different sectors (VLTO (Industrials) and DHR (Healthcare) and WAT (Healthcare) and TMO (Healthcare) and A (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

DHR, A pay a dividend while VLTO, WAT, TMO do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

VLTO

Stable Dividend Mega-Cap

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 10%
Run This Screen
Stocks Like

DHR

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

WAT

High-Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 45%
  • Net Margin > 7%
Run This Screen
Stocks Like

TMO

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 9%
Run This Screen
Stocks Like

A

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 10%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform VLTO and DHR and WAT and TMO and A on the metrics below

Revenue Growth>
%
(VLTO: 6.8% · DHR: 3.7%)
Net Margin>
%
(VLTO: 17.3% · DHR: 14.9%)
P/E Ratio<
x
(VLTO: 23.6x · DHR: 34.9x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.